Search results
Results from the WOW.Com Content Network
Laser lithotripsy (LL) has been evaluated against Extracorporeal Shock Wave lithotripsy (ESWL), finding both to be safe and effective. [3] [4] ESWL may be safer for small stones (<10 mm), but less effective for 10–20 mm stones. [3] A 2013 meta-analysis found LL can treat larger stones (> 2 cm) with good stone-free and complication rates. [5]
Lithotripsy is a procedure involving the physical destruction of hardened masses like kidney stones, [1] bezoars [2] or gallstones, which may be done non-invasively. The term is derived from the Greek words meaning "breaking (or pulverizing) stones" ( litho- + τρίψω [tripso]).
The total cost for treating urolithiasis was US$2 billion in 2003. [59] About 65–80% of those with kidney stones are men; most stones in women are due to either metabolic defects (such as cystinuria) or infections in the case of struvite stones. [76] [122] [19] Urinary tract calculi
Original Medicare (Parts A and B) does not cover gym memberships because they do not consider these services to be medically necessary.. Under Original Medicare, a person is responsible for 100% ...
The high-cut legs on the Streamline suit are particularly great for wider hips, as is the scoop in back. It also comes in long torso sizes, so everyone can get in on the sleek, chic fun. $180 at ...
Loosening up the quads, hip flexors and piriformis [a muscle running from the lower spine to the top of the thighs] – will really help you loosen up the hips, and [ease] the nagging lower back ...
Electrohydraulic Lithotripsy (EHL) is a medical procedure which uses targeted shockwaves to break up kidney stones and gallstones. [1] This form of extracorporeal lithotripsy is unique in that the shockwaves are produced by a vaporization bubble expanding and collapsing repeatedly, creating a pressure wave. [ 1 ]
The development of the Dornier lithotripter progressed through several prototypes, ultimately culminating in February 1980 with the first treatment of a human by shockwave lithotripsy (SWL). The production and distribution of the Dornier HM3 lithotripter began in late 1983, and SWL was approved by the U.S. Food and Drug Administration in 1984. [27]